POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)
1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Seq.
Identity (%)		 View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1JU6_A_LYAA317_1
(THYMIDYLATE SYNTHASE)		1hvy THYMIDYLATE SYNTHASE
(Homo
sapiens)		11 / 11PHE A  80
ILE A 108
TRP A 109
ASN A 112
ASP A 218
LEU A 221
GLY A 222
PHE A 225
TYR A 258
MET A 311
ALA A 312
D16  A 414 (-3.7A)
D16  A 414 (-3.7A)
D16  A 414 (-3.7A)
D16  A 414 ( 4.0A)
D16  A 414 ( 3.6A)
D16  A 414 (-4.0A)
D16  A 414 (-3.3A)
D16  A 414 (-3.6A)
UMP  A 314 ( 4.4A)
D16  A 414 (-3.4A)
D16  A 414 (-3.6A)
0.78A99.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JU6_A_LYAA317_1
(THYMIDYLATE SYNTHASE)		2efl FORMIN-BINDING
PROTEIN 1
(Homo
sapiens)		5 / 11PHE A  11
ILE A 216
LEU A   7
GLY A   4
PHE A 213
None
1.30A19.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JU6_A_LYAA317_1
(THYMIDYLATE SYNTHASE)		2eu9 DUAL SPECIFICITY
PROTEIN KINASE CLK3
(Homo
sapiens)		5 / 11PHE A 167
ILE A 188
ASN A 227
ASP A 138
GLY A 142
None
1.37A20.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JU6_A_LYAA317_1
(THYMIDYLATE SYNTHASE)		3eo3 BIFUNCTIONAL
UDP-N-ACETYLGLUCOSAM
INE
2-EPIMERASE/N-ACETYL
MANNOSAMINE KINASE
(Homo
sapiens)		5 / 11ILE A 541
ASN A 516
LEU A 567
GLY A 568
ALA A 564
None
1.12A20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JU6_A_LYAA317_1
(THYMIDYLATE SYNTHASE)		4cak INTEGRIN BETA-3
(Homo
sapiens)		5 / 11PHE B 153
ILE B 131
LEU B 138
GLY B 135
PHE B 203
None
1.36A17.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JU6_A_LYAA317_1
(THYMIDYLATE SYNTHASE)		4krf PROTEIN ARGONAUTE-1
(Homo
sapiens)		5 / 11ILE A 516
ASP A 535
GLY A 534
PHE A 503
TYR A 855
None
1.38A17.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JU6_A_LYAA317_1
(THYMIDYLATE SYNTHASE)		5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)		5 / 11ILE A 519
ASP A 538
GLY A 537
PHE A 506
TYR A 858
None
1.37A16.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JU6_A_LYAA317_1
(THYMIDYLATE SYNTHASE)		5vzt F-BOX ONLY PROTEIN
31
(Homo
sapiens)		5 / 11ILE B 145
ASN B 518
LEU B 160
GLY B 171
TYR B 174
None
1.40A13.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JU6_A_LYAA317_1
(THYMIDYLATE SYNTHASE)		6eti ATP-BINDING CASSETTE
SUB-FAMILY G MEMBER
2
(Homo
sapiens)		5 / 11ILE A 239
ASP A 254
LEU A  75
GLY A  74
ALA A 270
None
1.27A14.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1JU6_B_LYAB315_1
(THYMIDYLATE SYNTHASE)		1hvy THYMIDYLATE SYNTHASE
(Homo
sapiens)		9 / 9LYS A  77
ILE A 108
TRP A 109
ASN A 112
ASP A 218
LEU A 221
GLY A 222
TYR A 258
MET A 311
D16  A 414 ( 4.3A)
D16  A 414 (-3.7A)
D16  A 414 (-3.7A)
D16  A 414 ( 4.0A)
D16  A 414 ( 3.6A)
D16  A 414 (-4.0A)
D16  A 414 (-3.3A)
UMP  A 314 ( 4.4A)
D16  A 414 (-3.4A)
0.66A99.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JU6_B_LYAB315_1
(THYMIDYLATE SYNTHASE)		5vzt F-BOX ONLY PROTEIN
31
(Homo
sapiens)		5 / 9ILE B 145
ASN B 518
LEU B 160
GLY B 171
TYR B 174
None
1.40A13.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1JU6_C_LYAC315_1
(THYMIDYLATE SYNTHASE)		1hvy THYMIDYLATE SYNTHASE
(Homo
sapiens)		10 / 10ILE A 108
TRP A 109
ASN A 112
ASP A 218
LEU A 221
GLY A 222
PHE A 225
TYR A 258
MET A 311
ALA A 312
D16  A 414 (-3.7A)
D16  A 414 (-3.7A)
D16  A 414 ( 4.0A)
D16  A 414 ( 3.6A)
D16  A 414 (-4.0A)
D16  A 414 (-3.3A)
D16  A 414 (-3.6A)
UMP  A 314 ( 4.4A)
D16  A 414 (-3.4A)
D16  A 414 (-3.6A)
0.81A99.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JU6_C_LYAC315_1
(THYMIDYLATE SYNTHASE)		1zkl HIGH-AFFINITY
CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 7A
(Homo
sapiens)		5 / 10ILE A 158
ASN A 365
PHE A 156
TYR A 227
ALA A 361
None
IBM  A 503 ( 4.7A)
None
None
None
1.24A20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JU6_C_LYAC315_1
(THYMIDYLATE SYNTHASE)		3eo3 BIFUNCTIONAL
UDP-N-ACETYLGLUCOSAM
INE
2-EPIMERASE/N-ACETYL
MANNOSAMINE KINASE
(Homo
sapiens)		5 / 10ILE A 541
ASN A 516
LEU A 567
GLY A 568
ALA A 564
None
1.12A20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JU6_C_LYAC315_1
(THYMIDYLATE SYNTHASE)		4krf PROTEIN ARGONAUTE-1
(Homo
sapiens)		5 / 10ILE A 516
ASP A 535
GLY A 534
PHE A 503
TYR A 855
None
1.38A17.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JU6_C_LYAC315_1
(THYMIDYLATE SYNTHASE)		5lub LEGUMAIN
(Homo
sapiens)		5 / 10ILE B  87
ASP B  48
GLY B 230
TYR B 144
ALA B  52
None
1.45A20.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JU6_C_LYAC315_1
(THYMIDYLATE SYNTHASE)		5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)		5 / 10ILE A 519
ASP A 538
GLY A 537
PHE A 506
TYR A 858
None
1.37A16.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JU6_C_LYAC315_1
(THYMIDYLATE SYNTHASE)		6eti ATP-BINDING CASSETTE
SUB-FAMILY G MEMBER
2
(Homo
sapiens)		5 / 10ILE A 239
ASP A 254
LEU A  75
GLY A  74
ALA A 270
None
1.28A14.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1JU6_D_LYAD315_1
(THYMIDYLATE SYNTHASE)		1hvy THYMIDYLATE SYNTHASE
(Homo
sapiens)		11 / 11LYS A  77
PHE A  80
ILE A 108
TRP A 109
ASN A 112
ASP A 218
LEU A 221
GLY A 222
TYR A 258
MET A 311
ALA A 312
D16  A 414 ( 4.3A)
D16  A 414 (-3.7A)
D16  A 414 (-3.7A)
D16  A 414 (-3.7A)
D16  A 414 ( 4.0A)
D16  A 414 ( 3.6A)
D16  A 414 (-4.0A)
D16  A 414 (-3.3A)
UMP  A 314 ( 4.4A)
D16  A 414 (-3.4A)
D16  A 414 (-3.6A)
0.67A99.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JU6_D_LYAD315_1
(THYMIDYLATE SYNTHASE)		2eu9 DUAL SPECIFICITY
PROTEIN KINASE CLK3
(Homo
sapiens)		5 / 11PHE A 167
ILE A 188
ASN A 227
ASP A 138
GLY A 142
None
1.36A20.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JU6_D_LYAD315_1
(THYMIDYLATE SYNTHASE)		3eo3 BIFUNCTIONAL
UDP-N-ACETYLGLUCOSAM
INE
2-EPIMERASE/N-ACETYL
MANNOSAMINE KINASE
(Homo
sapiens)		5 / 11ILE A 541
ASN A 516
LEU A 567
GLY A 568
ALA A 564
None
1.13A20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JU6_D_LYAD315_1
(THYMIDYLATE SYNTHASE)		5lub LEGUMAIN
(Homo
sapiens)		5 / 11ILE B  87
ASP B  48
GLY B 230
TYR B 144
ALA B  52
None
1.45A20.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JU6_D_LYAD315_1
(THYMIDYLATE SYNTHASE)		5vzt F-BOX ONLY PROTEIN
31
(Homo
sapiens)		5 / 11ILE B 145
ASN B 518
LEU B 160
GLY B 171
TYR B 174
None
1.40A13.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JU6_D_LYAD315_1
(THYMIDYLATE SYNTHASE)		6eti ATP-BINDING CASSETTE
SUB-FAMILY G MEMBER
2
(Homo
sapiens)		5 / 11ILE A 239
ASP A 254
LEU A  75
GLY A  74
ALA A 270
None
1.27A14.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1JUJ_A_LYAA315_1
(THYMIDYLATE SYNTHASE)		1hvy THYMIDYLATE SYNTHASE
(Homo
sapiens)		9 / 10ILE A 108
TRP A 109
ASN A 112
ASP A 218
LEU A 221
GLY A 222
PHE A 225
TYR A 258
MET A 311
D16  A 414 (-3.7A)
D16  A 414 (-3.7A)
D16  A 414 ( 4.0A)
D16  A 414 ( 3.6A)
D16  A 414 (-4.0A)
D16  A 414 (-3.3A)
D16  A 414 (-3.6A)
UMP  A 314 ( 4.4A)
D16  A 414 (-3.4A)
0.84A99.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1JUJ_A_LYAA315_1
(THYMIDYLATE SYNTHASE)		1hvy THYMIDYLATE SYNTHASE
(Homo
sapiens)		9 / 10LYS A  77
ILE A 108
TRP A 109
ASN A 112
ASP A 218
LEU A 221
GLY A 222
TYR A 258
MET A 311
D16  A 414 ( 4.3A)
D16  A 414 (-3.7A)
D16  A 414 (-3.7A)
D16  A 414 ( 4.0A)
D16  A 414 ( 3.6A)
D16  A 414 (-4.0A)
D16  A 414 (-3.3A)
UMP  A 314 ( 4.4A)
D16  A 414 (-3.4A)
0.63A99.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JUJ_A_LYAA315_1
(THYMIDYLATE SYNTHASE)		4krf PROTEIN ARGONAUTE-1
(Homo
sapiens)		5 / 10ILE A 516
ASP A 535
GLY A 534
PHE A 503
TYR A 855
None
1.35A17.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JUJ_A_LYAA315_1
(THYMIDYLATE SYNTHASE)		4qae NEUTROPHIL
GELATINASE-ASSOCIATE
D LIPOCALIN
(Homo
sapiens)		5 / 10ILE A 166
LEU A 137
GLY A  35
PHE A 168
TYR A 138
None
1.38A21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JUJ_A_LYAA315_1
(THYMIDYLATE SYNTHASE)		4qae NEUTROPHIL
GELATINASE-ASSOCIATE
D LIPOCALIN
(Homo
sapiens)		5 / 10LEU A 137
GLY A  35
PHE A 168
TYR A 138
MET A 120
None
1.45A21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JUJ_A_LYAA315_1
(THYMIDYLATE SYNTHASE)		5khp NEUTROPHIL
GELATINASE-ASSOCIATE
D LIPOCALIN
(Homo
sapiens)		5 / 10ILE A 166
LEU A 137
GLY A  35
PHE A 168
TYR A 138
None
1.39A22.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JUJ_A_LYAA315_1
(THYMIDYLATE SYNTHASE)		5khp NEUTROPHIL
GELATINASE-ASSOCIATE
D LIPOCALIN
(Homo
sapiens)		5 / 10LEU A 137
GLY A  35
PHE A 168
TYR A 138
MET A 120
None
1.47A22.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JUJ_A_LYAA315_1
(THYMIDYLATE SYNTHASE)		5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)		5 / 10ILE A 519
ASP A 538
GLY A 537
PHE A 506
TYR A 858
None
1.36A16.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JUJ_A_LYAA315_1
(THYMIDYLATE SYNTHASE)		5vzt F-BOX ONLY PROTEIN
31
(Homo
sapiens)		5 / 10ILE B 145
ASN B 518
LEU B 160
GLY B 171
TYR B 174
None
1.35A13.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1JUJ_B_LYAB315_1
(THYMIDYLATE SYNTHASE)		1hvy THYMIDYLATE SYNTHASE
(Homo
sapiens)		9 / 10ILE A 108
TRP A 109
ASN A 112
ASP A 218
LEU A 221
GLY A 222
PHE A 225
TYR A 258
MET A 311
D16  A 414 (-3.7A)
D16  A 414 (-3.7A)
D16  A 414 ( 4.0A)
D16  A 414 ( 3.6A)
D16  A 414 (-4.0A)
D16  A 414 (-3.3A)
D16  A 414 (-3.6A)
UMP  A 314 ( 4.4A)
D16  A 414 (-3.4A)
0.84A99.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1JUJ_B_LYAB315_1
(THYMIDYLATE SYNTHASE)		1hvy THYMIDYLATE SYNTHASE
(Homo
sapiens)		9 / 10LYS A  77
ILE A 108
TRP A 109
ASN A 112
ASP A 218
LEU A 221
GLY A 222
TYR A 258
MET A 311
D16  A 414 ( 4.3A)
D16  A 414 (-3.7A)
D16  A 414 (-3.7A)
D16  A 414 ( 4.0A)
D16  A 414 ( 3.6A)
D16  A 414 (-4.0A)
D16  A 414 (-3.3A)
UMP  A 314 ( 4.4A)
D16  A 414 (-3.4A)
0.63A99.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JUJ_B_LYAB315_1
(THYMIDYLATE SYNTHASE)		4krf PROTEIN ARGONAUTE-1
(Homo
sapiens)		5 / 10ILE A 516
ASP A 535
GLY A 534
PHE A 503
TYR A 855
None
1.35A17.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JUJ_B_LYAB315_1
(THYMIDYLATE SYNTHASE)		4qae NEUTROPHIL
GELATINASE-ASSOCIATE
D LIPOCALIN
(Homo
sapiens)		5 / 10ILE A 166
LEU A 137
GLY A  35
PHE A 168
TYR A 138
None
1.38A21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JUJ_B_LYAB315_1
(THYMIDYLATE SYNTHASE)		4qae NEUTROPHIL
GELATINASE-ASSOCIATE
D LIPOCALIN
(Homo
sapiens)		5 / 10LEU A 137
GLY A  35
PHE A 168
TYR A 138
MET A 120
None
1.46A21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JUJ_B_LYAB315_1
(THYMIDYLATE SYNTHASE)		5khp NEUTROPHIL
GELATINASE-ASSOCIATE
D LIPOCALIN
(Homo
sapiens)		5 / 10ILE A 166
LEU A 137
GLY A  35
PHE A 168
TYR A 138
None
1.39A22.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JUJ_B_LYAB315_1
(THYMIDYLATE SYNTHASE)		5khp NEUTROPHIL
GELATINASE-ASSOCIATE
D LIPOCALIN
(Homo
sapiens)		5 / 10LEU A 137
GLY A  35
PHE A 168
TYR A 138
MET A 120
None
1.47A22.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JUJ_B_LYAB315_1
(THYMIDYLATE SYNTHASE)		5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)		5 / 10ILE A 519
ASP A 538
GLY A 537
PHE A 506
TYR A 858
None
1.36A16.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JUJ_B_LYAB315_1
(THYMIDYLATE SYNTHASE)		5vzt F-BOX ONLY PROTEIN
31
(Homo
sapiens)		5 / 10ILE B 145
ASN B 518
LEU B 160
GLY B 171
TYR B 174
None
1.35A13.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1JUJ_C_LYAC315_1
(THYMIDYLATE SYNTHASE)		1hvy THYMIDYLATE SYNTHASE
(Homo
sapiens)		9 / 10ILE A 108
TRP A 109
ASN A 112
ASP A 218
LEU A 221
GLY A 222
PHE A 225
TYR A 258
MET A 311
D16  A 414 (-3.7A)
D16  A 414 (-3.7A)
D16  A 414 ( 4.0A)
D16  A 414 ( 3.6A)
D16  A 414 (-4.0A)
D16  A 414 (-3.3A)
D16  A 414 (-3.6A)
UMP  A 314 ( 4.4A)
D16  A 414 (-3.4A)
0.84A99.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1JUJ_C_LYAC315_1
(THYMIDYLATE SYNTHASE)		1hvy THYMIDYLATE SYNTHASE
(Homo
sapiens)		9 / 10LYS A  77
ILE A 108
TRP A 109
ASN A 112
ASP A 218
LEU A 221
GLY A 222
TYR A 258
MET A 311
D16  A 414 ( 4.3A)
D16  A 414 (-3.7A)
D16  A 414 (-3.7A)
D16  A 414 ( 4.0A)
D16  A 414 ( 3.6A)
D16  A 414 (-4.0A)
D16  A 414 (-3.3A)
UMP  A 314 ( 4.4A)
D16  A 414 (-3.4A)
0.63A99.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JUJ_C_LYAC315_1
(THYMIDYLATE SYNTHASE)		4krf PROTEIN ARGONAUTE-1
(Homo
sapiens)		5 / 10ILE A 516
ASP A 535
GLY A 534
PHE A 503
TYR A 855
None
1.35A17.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JUJ_C_LYAC315_1
(THYMIDYLATE SYNTHASE)		4qae NEUTROPHIL
GELATINASE-ASSOCIATE
D LIPOCALIN
(Homo
sapiens)		5 / 10ILE A 166
LEU A 137
GLY A  35
PHE A 168
TYR A 138
None
1.38A21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JUJ_C_LYAC315_1
(THYMIDYLATE SYNTHASE)		4qae NEUTROPHIL
GELATINASE-ASSOCIATE
D LIPOCALIN
(Homo
sapiens)		5 / 10LEU A 137
GLY A  35
PHE A 168
TYR A 138
MET A 120
None
1.46A21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JUJ_C_LYAC315_1
(THYMIDYLATE SYNTHASE)		5khp NEUTROPHIL
GELATINASE-ASSOCIATE
D LIPOCALIN
(Homo
sapiens)		5 / 10ILE A 166
LEU A 137
GLY A  35
PHE A 168
TYR A 138
None
1.39A22.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JUJ_C_LYAC315_1
(THYMIDYLATE SYNTHASE)		5khp NEUTROPHIL
GELATINASE-ASSOCIATE
D LIPOCALIN
(Homo
sapiens)		5 / 10LEU A 137
GLY A  35
PHE A 168
TYR A 138
MET A 120
None
1.47A22.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JUJ_C_LYAC315_1
(THYMIDYLATE SYNTHASE)		5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)		5 / 10ILE A 519
ASP A 538
GLY A 537
PHE A 506
TYR A 858
None
1.36A16.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JUJ_C_LYAC315_1
(THYMIDYLATE SYNTHASE)		5vzt F-BOX ONLY PROTEIN
31
(Homo
sapiens)		5 / 10ILE B 145
ASN B 518
LEU B 160
GLY B 171
TYR B 174
None
1.35A13.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1JUJ_D_LYAD315_1
(THYMIDYLATE SYNTHASE)		1hvy THYMIDYLATE SYNTHASE
(Homo
sapiens)		9 / 10ILE A 108
TRP A 109
ASN A 112
ASP A 218
LEU A 221
GLY A 222
PHE A 225
TYR A 258
MET A 311
D16  A 414 (-3.7A)
D16  A 414 (-3.7A)
D16  A 414 ( 4.0A)
D16  A 414 ( 3.6A)
D16  A 414 (-4.0A)
D16  A 414 (-3.3A)
D16  A 414 (-3.6A)
UMP  A 314 ( 4.4A)
D16  A 414 (-3.4A)
0.84A99.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1JUJ_D_LYAD315_1
(THYMIDYLATE SYNTHASE)		1hvy THYMIDYLATE SYNTHASE
(Homo
sapiens)		9 / 10LYS A  77
ILE A 108
TRP A 109
ASN A 112
ASP A 218
LEU A 221
GLY A 222
TYR A 258
MET A 311
D16  A 414 ( 4.3A)
D16  A 414 (-3.7A)
D16  A 414 (-3.7A)
D16  A 414 ( 4.0A)
D16  A 414 ( 3.6A)
D16  A 414 (-4.0A)
D16  A 414 (-3.3A)
UMP  A 314 ( 4.4A)
D16  A 414 (-3.4A)
0.63A99.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JUJ_D_LYAD315_1
(THYMIDYLATE SYNTHASE)		4krf PROTEIN ARGONAUTE-1
(Homo
sapiens)		5 / 10ILE A 516
ASP A 535
GLY A 534
PHE A 503
TYR A 855
None
1.35A17.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JUJ_D_LYAD315_1
(THYMIDYLATE SYNTHASE)		4qae NEUTROPHIL
GELATINASE-ASSOCIATE
D LIPOCALIN
(Homo
sapiens)		5 / 10ILE A 166
LEU A 137
GLY A  35
PHE A 168
TYR A 138
None
1.38A21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JUJ_D_LYAD315_1
(THYMIDYLATE SYNTHASE)		4qae NEUTROPHIL
GELATINASE-ASSOCIATE
D LIPOCALIN
(Homo
sapiens)		5 / 10LEU A 137
GLY A  35
PHE A 168
TYR A 138
MET A 120
None
1.45A21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JUJ_D_LYAD315_1
(THYMIDYLATE SYNTHASE)		5khp NEUTROPHIL
GELATINASE-ASSOCIATE
D LIPOCALIN
(Homo
sapiens)		5 / 10ILE A 166
LEU A 137
GLY A  35
PHE A 168
TYR A 138
None
1.40A22.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JUJ_D_LYAD315_1
(THYMIDYLATE SYNTHASE)		5khp NEUTROPHIL
GELATINASE-ASSOCIATE
D LIPOCALIN
(Homo
sapiens)		5 / 10LEU A 137
GLY A  35
PHE A 168
TYR A 138
MET A 120
None
1.47A22.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JUJ_D_LYAD315_1
(THYMIDYLATE SYNTHASE)		5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)		5 / 10ILE A 519
ASP A 538
GLY A 537
PHE A 506
TYR A 858
None
1.36A16.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JUJ_D_LYAD315_1
(THYMIDYLATE SYNTHASE)		5vzt F-BOX ONLY PROTEIN
31
(Homo
sapiens)		5 / 10ILE B 145
ASN B 518
LEU B 160
GLY B 171
TYR B 174
None
1.35A13.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X9G_A_LYAA1270_1
(PTERIDINE REDUCTASE)		4i5j SERINE/THREONINE-PRO
TEIN PHOSPHATASE 2A
REGULATORY SUBUNIT
B'' SUBUNIT ALPHA
(Homo
sapiens)		5 / 12SER A 252
PHE A 254
PHE A 274
TYR A 273
LEU A 184
None
1.44A20.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X9G_A_LYAA1270_1
(PTERIDINE REDUCTASE)		5nn8 LYSOSOMAL
ALPHA-GLUCOSIDASE
(Homo
sapiens)		5 / 12PHE A 240
PRO A  94
ASP A 163
PHE A 159
PRO A 238
None
1.37A16.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X9G_A_LYAA1270_2
(PTERIDINE REDUCTASE)		1jpl ADP-RIBOSYLATION
FACTOR BINDING
PROTEIN GGA3
(Homo
sapiens)		3 / 3MET A 123
VAL A  84
GLU A  70
None
0.83A22.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X9G_A_LYAA1270_2
(PTERIDINE REDUCTASE)		1wfg REGULATING SYNAPTIC
MEMBRANE EXOCYTOSIS
PROTEIN 2
(Homo
sapiens)		3 / 3MET A  59
VAL A  54
GLU A 105
None
0.92A19.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X9G_A_LYAA1270_2
(PTERIDINE REDUCTASE)		1x44 MYOSIN-BINDING
PROTEIN C, SLOW-TYPE
(Homo
sapiens)		3 / 3MET A  82
VAL A  59
GLU A  33
None
0.66A16.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X9G_A_LYAA1270_2
(PTERIDINE REDUCTASE)		2dnw ACYL CARRIER PROTEIN
(Homo
sapiens)		3 / 3MET A  76
VAL A  23
GLU A  60
None
0.86A16.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X9G_A_LYAA1270_2
(PTERIDINE REDUCTASE)		2lav VACCINIA-RELATED
KINASE 1
(Homo
sapiens)		3 / 3MET A  56
VAL A  25
GLU A  60
None
0.85A22.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X9G_A_LYAA1270_2
(PTERIDINE REDUCTASE)		3dlj BETA-ALA-HIS
DIPEPTIDASE
(Homo
sapiens)		3 / 3MET A 224
VAL A 266
GLU A 369
None
0.90A21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X9G_A_LYAA1270_2
(PTERIDINE REDUCTASE)		4e3c INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT BETA
(Homo
sapiens)		3 / 3MET A 280
VAL A 245
GLU A 240
None
0.78A17.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X9G_A_LYAA1270_2
(PTERIDINE REDUCTASE)		4f2a CHOLESTERYL ESTER
TRANSFER PROTEIN
(Homo
sapiens)		3 / 3MET A 284
VAL A 427
GLU A 291
None
0.89A22.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X9G_A_LYAA1270_2
(PTERIDINE REDUCTASE)		4i6j F-BOX/LRR-REPEAT
PROTEIN 3
(Homo
sapiens)		3 / 3MET B 329
VAL B 339
GLU B 298
None
0.86A21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X9G_A_LYAA1270_2
(PTERIDINE REDUCTASE)		4ol0 TRANSPORTIN-3
(Homo
sapiens)		3 / 3MET B 199
VAL B 180
GLU B 152
None
0.77A15.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X9G_A_LYAA1270_2
(PTERIDINE REDUCTASE)		4pj3 INTRON-BINDING
PROTEIN AQUARIUS
(Homo
sapiens)		3 / 3MET A  92
VAL A  23
GLU A 100
None
0.83A11.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X9G_A_LYAA1270_2
(PTERIDINE REDUCTASE)		4zg7 ECTONUCLEOTIDE
PYROPHOSPHATASE/PHOS
PHODIESTERASE FAMILY
MEMBER 2
(Homo
sapiens)		3 / 3MET A 822
VAL A 791
GLU A 505
GOL  A 914 (-3.6A)
None
None
0.83A16.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X9G_B_LYAB1270_1
(PTERIDINE REDUCTASE)		4i5j SERINE/THREONINE-PRO
TEIN PHOSPHATASE 2A
REGULATORY SUBUNIT
B'' SUBUNIT ALPHA
(Homo
sapiens)		5 / 12SER A 252
PHE A 254
PHE A 274
TYR A 273
LEU A 184
None
1.41A20.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X9G_B_LYAB1270_1
(PTERIDINE REDUCTASE)		5nn8 LYSOSOMAL
ALPHA-GLUCOSIDASE
(Homo
sapiens)		5 / 12PHE A 240
PRO A  94
ASP A 163
PHE A 159
PRO A 238
None
1.39A16.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X9G_C_LYAC1270_1
(PTERIDINE REDUCTASE)		4i5j SERINE/THREONINE-PRO
TEIN PHOSPHATASE 2A
REGULATORY SUBUNIT
B'' SUBUNIT ALPHA
(Homo
sapiens)		5 / 12SER A 252
PHE A 254
PHE A 274
TYR A 273
LEU A 184
None
1.40A20.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X9G_C_LYAC1270_1
(PTERIDINE REDUCTASE)		5nn8 LYSOSOMAL
ALPHA-GLUCOSIDASE
(Homo
sapiens)		5 / 12PHE A 240
PRO A  94
ASP A 163
PHE A 159
PRO A 238
None
1.37A16.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X9G_D_LYAD1270_1
(PTERIDINE REDUCTASE)		4i5j SERINE/THREONINE-PRO
TEIN PHOSPHATASE 2A
REGULATORY SUBUNIT
B'' SUBUNIT ALPHA
(Homo
sapiens)		5 / 12SER A 252
PHE A 254
PHE A 274
TYR A 273
LEU A 184
None
1.43A20.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X9G_D_LYAD1270_1
(PTERIDINE REDUCTASE)		5nn8 LYSOSOMAL
ALPHA-GLUCOSIDASE
(Homo
sapiens)		5 / 12PHE A 240
PRO A  94
ASP A 163
PHE A 159
PRO A 238
None
1.37A16.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K2H_A_LYAA513_1
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		1hvy THYMIDYLATE SYNTHASE
(Homo
sapiens)		9 / 12GLU A  87
ILE A 108
TRP A 109
LEU A 192
ASP A 218
LEU A 221
GLY A 222
TYR A 258
MET A 311
D16  A 414 (-3.8A)
D16  A 414 (-3.7A)
D16  A 414 (-3.7A)
None
D16  A 414 ( 3.6A)
D16  A 414 (-4.0A)
D16  A 414 (-3.3A)
UMP  A 314 ( 4.4A)
D16  A 414 (-3.4A)
0.66A51.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K2H_A_LYAA513_1
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		1hvy THYMIDYLATE SYNTHASE
(Homo
sapiens)		7 / 12ILE A 108
TRP A 109
LEU A 192
GLY A 222
PHE A 225
TYR A 258
MET A 311
D16  A 414 (-3.7A)
D16  A 414 (-3.7A)
None
D16  A 414 (-3.3A)
D16  A 414 (-3.6A)
UMP  A 314 ( 4.4A)
D16  A 414 (-3.4A)
0.98A51.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_A_LYAA513_1
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		2xn6 THYROXINE-BINDING
GLOBULIN
(Homo
sapiens)		5 / 12ALA A 308
LEU A 127
LEU A 324
PHE A 315
MET A 178
None
1.12A21.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_A_LYAA513_1
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		2ygq WNT INHIBITORY
FACTOR 1
(Homo
sapiens)		5 / 12ILE A 263
LEU A 104
GLY A 125
PHE A 257
MET A 157
None
1.16A21.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_A_LYAA513_1
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		4fl3 TYROSINE-PROTEIN
KINASE SYK
(Homo
sapiens)		5 / 12ALA A 521
SER A 516
LEU A 501
GLY A 380
PHE A 382
None
None
ANP  A 701 (-4.5A)
ANP  A 701 (-3.5A)
None
1.09A22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_A_LYAA513_1
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		5nqa POLYPEPTIDE
N-ACETYLGALACTOSAMIN
YLTRANSFERASE 4
(Homo
sapiens)		5 / 12GLU A 231
ILE A 259
LEU A 106
GLY A  78
PHE A 266
EDO  A 604 (-3.4A)
None
None
None
None
1.11A8.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_A_LYAA514_1
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		1ldk CULLIN HOMOLOG
(Homo
sapiens)		5 / 12ALA B 656
THR B 667
ILE B 669
LEU B 640
LEU B 663
None
1.02A19.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_A_LYAA514_1
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		1u71 DIHYDROFOLATE
REDUCTASE
(Homo
sapiens)		6 / 12ALA A   9
THR A  56
ILE A  60
LEU A  67
ARG A  70
TYR A 121
MXA  A 187 (-3.6A)
SO4  A 188 (-3.5A)
MXA  A 187 ( 4.7A)
None
None
None
0.45A23.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_A_LYAA514_1
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		1xa6 BETA2-CHIMAERIN
(Homo
sapiens)		5 / 12LEU A 458
THR A 366
ILE A 362
LEU A 401
LEU A 390
None
1.11A20.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_A_LYAA514_1
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		2dh3 4F2 CELL-SURFACE
ANTIGEN HEAVY CHAIN
(Homo
sapiens)		5 / 12ALA A 137
PHE A 132
LEU A 129
LEU A 160
LEU A 140
None
0.91A21.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_A_LYAA514_1
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		2xh1 KYNURENINE/ALPHA-AMI
NOADIPATE
AMINOTRANSFERASE,
MITOCHONDRIAL
(Homo
sapiens)		5 / 12LEU A 417
ILE A 363
SER A 424
LEU A 369
LEU A 398
None
1.13A23.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_A_LYAA514_1
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		3fjo NADPH-CYTOCHROME
P450 REDUCTASE
(Homo
sapiens;
Saccharomyces
cerevisiae)		6 / 12ALA A  51
PHE A 101
LEU A 104
ILE A 113
LEU A 171
LEU A 145
None
1.44A22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_A_LYAA514_1
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		3o47 ADP-RIBOSYLATION
FACTOR
GTPASE-ACTIVATING
PROTEIN 1,
ADP-RIBOSYLATION
FACTOR 1
(Homo
sapiens)		5 / 12LEU A 237
ARG A 234
ILE A 285
LEU A 275
LEU A 251
None
1.08A19.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_A_LYAA514_1
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		4xbr PROTEIN
FAM212A,SERINE/THREO
NINE-PROTEIN KINASE
PAK 4
(Homo
sapiens)		5 / 12ALA A 463
ILE A 441
SER A 445
LEU A 456
LEU A 431
SEP  A 474 ( 4.1A)
None
MG  A 603 ( 4.0A)
None
None
1.06A21.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_A_LYAA514_1
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		5of4 TFIIH BASAL
TRANSCRIPTION FACTOR
COMPLEX HELICASE XPD
SUBUNIT
(Homo
sapiens)		5 / 12LEU B 567
ILE B 535
SER B 528
LEU B 524
LEU B 597
None
1.15A21.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_A_LYAA514_1
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		5wc2 PACHYTENE CHECKPOINT
PROTEIN 2 HOMOLOG
(Homo
sapiens)		5 / 12ASP A 285
LEU A 281
THR A 297
ILE A 251
LEU A 257
None
1.12A9.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K2H_B_LYAB513_1
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		1hvy THYMIDYLATE SYNTHASE
(Homo
sapiens)		9 / 12GLU A  87
ILE A 108
TRP A 109
LEU A 192
ASP A 218
LEU A 221
GLY A 222
TYR A 258
MET A 311
D16  A 414 (-3.8A)
D16  A 414 (-3.7A)
D16  A 414 (-3.7A)
None
D16  A 414 ( 3.6A)
D16  A 414 (-4.0A)
D16  A 414 (-3.3A)
UMP  A 314 ( 4.4A)
D16  A 414 (-3.4A)
0.71A51.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K2H_B_LYAB513_1
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		1hvy THYMIDYLATE SYNTHASE
(Homo
sapiens)		8 / 12ILE A 108
TRP A 109
LEU A 192
ASP A 218
GLY A 222
PHE A 225
TYR A 258
MET A 311
D16  A 414 (-3.7A)
D16  A 414 (-3.7A)
None
D16  A 414 ( 3.6A)
D16  A 414 (-3.3A)
D16  A 414 (-3.6A)
UMP  A 314 ( 4.4A)
D16  A 414 (-3.4A)
0.97A51.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_B_LYAB513_1
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		2xn6 THYROXINE-BINDING
GLOBULIN
(Homo
sapiens)		5 / 12ALA A 308
LEU A 127
LEU A 324
PHE A 315
MET A 178
None
1.12A21.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_B_LYAB513_1
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		2ygq WNT INHIBITORY
FACTOR 1
(Homo
sapiens)		5 / 12ILE A 263
LEU A 104
GLY A 125
PHE A 257
MET A 157
None
1.15A21.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_B_LYAB513_1
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		4fl3 TYROSINE-PROTEIN
KINASE SYK
(Homo
sapiens)		5 / 12ALA A 521
SER A 516
LEU A 501
GLY A 380
PHE A 382
None
None
ANP  A 701 (-4.5A)
ANP  A 701 (-3.5A)
None
1.07A22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_B_LYAB513_1
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		5nqa POLYPEPTIDE
N-ACETYLGALACTOSAMIN
YLTRANSFERASE 4
(Homo
sapiens)		5 / 12GLU A 231
ILE A 259
LEU A 106
GLY A  78
PHE A 266
EDO  A 604 (-3.4A)
None
None
None
None
1.08A8.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_B_LYAB514_1
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		1u71 DIHYDROFOLATE
REDUCTASE
(Homo
sapiens)		6 / 12ALA A   9
SER A  59
ILE A  60
LEU A  67
ARG A  70
TYR A 121
MXA  A 187 (-3.6A)
MXA  A 187 (-3.8A)
MXA  A 187 ( 4.7A)
None
None
None
0.52A23.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_B_LYAB514_1
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		2ld4 ANAMORSIN
(Homo
sapiens)		5 / 12ALA A  13
ARG A  85
LEU A  87
SER A 122
LEU A 124
None
1.15A16.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_B_LYAB514_1
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		2r1v DJ-1
(Homo
sapiens)		5 / 12ALA A 104
ILE A 102
LEU A  82
ILE A  91
LEU A  58
None
1.15A16.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_B_LYAB514_1
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		2wjv REGULATOR OF
NONSENSE TRANSCRIPTS
1
(Homo
sapiens)		5 / 12ILE A 793
PHE A 852
LEU A 859
ILE A 872
LEU A 888
None
SO4  A 996 (-4.8A)
None
None
None
1.18A21.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_B_LYAB514_1
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		2y8f RAN-BINDING PROTEIN
3
(Homo
sapiens)		5 / 12ILE A 397
ARG A 374
LEU A 360
ILE A 422
LEU A 358
GOL  A1452 (-4.7A)
CL  A1449 ( 3.9A)
None
None
None
1.14A16.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_B_LYAB514_1
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		3ctz XAA-PRO
AMINOPEPTIDASE 1
(Homo
sapiens)		5 / 12ILE A 263
PHE A 209
LEU A 211
ILE A 237
SER A 224
None
1.13A20.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_B_LYAB514_1
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		4igg CATENIN ALPHA-1
(Homo
sapiens)		5 / 12ALA A 320
ARG A 380
LEU A 382
ILE A 312
LEU A 282
None
1.11A19.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_B_LYAB514_1
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		4pki GELSOLIN,TROPOMODULI
N-1 CHIMERA
(Homo
sapiens)		5 / 12ALA G1245
LEU G1276
ILE G1302
SER G1304
LEU G1306
None
1.16A20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_B_LYAB514_1
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		4r7p UTP--GLUCOSE-1-PHOSP
HATE
URIDYLYLTRANSFERASE
(Homo
sapiens)		6 / 12ALA A 492
LEU A 472
SER A 448
ILE A 449
SER A 406
LEU A 402
None
1.26A21.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_B_LYAB514_1
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		5bo6 SIA-ALPHA-2,3-GAL-BE
TA-1,4-GLCNAC-R:ALPH
A
2,8-SIALYLTRANSFERAS
E
(Homo
sapiens)		5 / 12PHE A 187
ARG A 188
SER A 310
ILE A 316
LEU A 318
None
1.18A20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_B_LYAB514_2
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		1k1b B-CELL LYMPHOMA
3-ENCODED PROTEIN
(Homo
sapiens)		3 / 3ARG A 181
THR A 166
THR A 224
None
0.81A19.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_B_LYAB514_2
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		1v5w MEIOTIC
RECOMBINATION
PROTEIN DMC1/LIM15
HOMOLOG
(Homo
sapiens)		3 / 3ARG A 166
THR A 142
THR A 267
None
0.56A22.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_B_LYAB514_2
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		2r55 STAR-RELATED LIPID
TRANSFER PROTEIN 5
(Homo
sapiens)		3 / 3ARG A 199
THR A 101
THR A 174
None
0.77A16.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_B_LYAB514_2
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		2z7x TOLL-LIKE RECEPTOR
2, VARIABLE
LYMPHOCYTE RECEPTOR
B
(Eptatretus
burgeri;
Homo
sapiens)		3 / 3ARG A 447
THR A 452
THR A 405
None
0.51A21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_B_LYAB514_2
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		3bg9 PYRUVATE
CARBOXYLASE,
MITOCHONDRIAL
(Homo
sapiens)		3 / 3ARG A 581
THR A 568
THR A 908
None
0.73A21.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_B_LYAB514_2
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		3qyn TUMOR PROTEIN 63
(Homo
sapiens)		3 / 3ARG A 227
THR A 262
THR A 152
None
0.81A15.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_B_LYAB514_2
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		3snh DYNAMIN-1
(Homo
sapiens)		3 / 3ARG A  59
THR A 141
THR A 105
None
0.81A22.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_B_LYAB514_2
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		3zcw KINESIN-LIKE PROTEIN
KIF11
(Homo
sapiens)		3 / 3ARG A 234
THR A 349
THR A 112
None
None
MG  A1365 ( 3.0A)
0.78A21.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_B_LYAB514_2
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		4owt INTEGRATOR COMPLEX
SUBUNIT 3
(Homo
sapiens)		3 / 3ARG A  54
THR A  63
THR A  99
None
0.70A22.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_B_LYAB514_2
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		5a31 ANAPHASE-PROMOTING
COMPLEX SUBUNIT 1
(Homo
sapiens)		3 / 3ARG A 871
THR A 946
THR A 620
None
0.78A16.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_B_LYAB514_2
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		5dgo CELL DIVISION
CONTROL PROTEIN 45
HOMOLOG
(Homo
sapiens)		3 / 3ARG A 406
THR A 360
THR A 380
None
EDO  A 602 ( 4.7A)
None
0.61A21.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_B_LYAB514_2
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		5du3 PLASMA PROTEASE C1
INHIBITOR
(Homo
sapiens)		3 / 3ARG A 227
THR A 409
THR A 263
None
0.79A22.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_B_LYAB514_2
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		5eod COAGULATION FACTOR
XI
(Homo
sapiens)		3 / 3ARG A 378
THR A 440
THR A 513
None
0.69A21.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_B_LYAB514_2
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		5h1c DNA REPAIR PROTEIN
RAD51 HOMOLOG 1
(Homo
sapiens)		3 / 3ARG A 167
THR A 143
THR A 266
None
0.80A22.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_B_LYAB514_2
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		5j6z ANASTELLIN
FIBRONECTIN
(Homo
sapiens)		3 / 3ARG A  26
THR B 103
THR B  97
None
0.68A4.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K2H_B_LYAB514_2
(DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE)		5wu3 SPECKLE TARGETED
PIP5K1A-REGULATED
POLY(A) POLYMERASE
(Homo
sapiens)		3 / 3ARG A 420
THR A 556
THR A 844
None
0.77A21.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4FQS_A_LYAA302_1
(THYMIDYLATE SYNTHASE)		1hvy THYMIDYLATE SYNTHASE
(Homo
sapiens)		8 / 12GLU A  87
ILE A 108
TRP A 109
ASP A 218
LEU A 221
GLY A 222
TYR A 258
ALA A 312
D16  A 414 (-3.8A)
D16  A 414 (-3.7A)
D16  A 414 (-3.7A)
D16  A 414 ( 3.6A)
D16  A 414 (-4.0A)
D16  A 414 (-3.3A)
UMP  A 314 ( 4.4A)
D16  A 414 (-3.6A)
0.63A50.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4FQS_A_LYAA302_1
(THYMIDYLATE SYNTHASE)		1hvy THYMIDYLATE SYNTHASE
(Homo
sapiens)		8 / 12ILE A 108
TRP A 109
ASP A 218
LEU A 221
GLY A 222
PHE A 225
TYR A 258
ALA A 312
D16  A 414 (-3.7A)
D16  A 414 (-3.7A)
D16  A 414 ( 3.6A)
D16  A 414 (-4.0A)
D16  A 414 (-3.3A)
D16  A 414 (-3.6A)
UMP  A 314 ( 4.4A)
D16  A 414 (-3.6A)
0.88A50.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FQS_A_LYAA302_1
(THYMIDYLATE SYNTHASE)		2i7a CALPAIN 13
(Homo
sapiens)		5 / 12ILE A 516
LEU A 566
PHE A 563
VAL A 547
ALA A 548
None
1.25A18.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FQS_A_LYAA302_1
(THYMIDYLATE SYNTHASE)		3ifw UBIQUITIN
CARBOXYL-TERMINAL
HYDROLASE ISOZYME L1
(Homo
sapiens)		5 / 12GLU A 109
LEU A 106
GLY A 107
VAL A  99
ALA A 100
None
1.24A20.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FQS_A_LYAA302_1
(THYMIDYLATE SYNTHASE)		3v96 STROMELYSIN-2
(Homo
sapiens)		5 / 12HIS B 195
ILE B 160
LEU B 211
VAL B 129
ALA B 128
 ZN  B 302 (-3.2A)
None
None
None
None
1.25A19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FQS_A_LYAA302_1
(THYMIDYLATE SYNTHASE)		4l1m E3 UBIQUITIN-PROTEIN
LIGASE HERC2
(Homo
sapiens)		5 / 12GLU A 424
ILE A 426
ASP A 759
GLY A 757
VAL A 730
None
1.25A20.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FQS_A_LYAA302_1
(THYMIDYLATE SYNTHASE)		4um8 INTEGRIN ALPHA-V
(Homo
sapiens)		5 / 12ILE A 433
GLY A 405
PHE A 404
VAL A  23
ALA A  22
None
1.23A17.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FQS_A_LYAA302_1
(THYMIDYLATE SYNTHASE)		5lst ATP-DEPENDENT DNA
HELICASE Q4
(Homo
sapiens)		5 / 12HIS A 930
ILE A1051
LEU A 923
VAL A 842
ALA A 841
None
1.02A16.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FQS_A_LYAA302_1
(THYMIDYLATE SYNTHASE)		5njj PROTEIN NUMB HOMOLOG
(Homo
sapiens)		5 / 12GLU A 112
LEU A  95
GLY A  94
VAL A 158
ALA A 157
None
1.23A16.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FQS_A_LYAA302_1
(THYMIDYLATE SYNTHASE)		6eti ATP-BINDING CASSETTE
SUB-FAMILY G MEMBER
2
(Homo
sapiens)		5 / 12ILE A 239
ASP A 254
LEU A  75
GLY A  74
ALA A 270
None
1.23A13.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4FQS_B_LYAB302_1
(THYMIDYLATE SYNTHASE)		1hvy THYMIDYLATE SYNTHASE
(Homo
sapiens)		8 / 12GLU A  87
ILE A 108
TRP A 109
ASP A 218
LEU A 221
GLY A 222
TYR A 258
ALA A 312
D16  A 414 (-3.8A)
D16  A 414 (-3.7A)
D16  A 414 (-3.7A)
D16  A 414 ( 3.6A)
D16  A 414 (-4.0A)
D16  A 414 (-3.3A)
UMP  A 314 ( 4.4A)
D16  A 414 (-3.6A)
0.65A50.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4FQS_B_LYAB302_1
(THYMIDYLATE SYNTHASE)		1hvy THYMIDYLATE SYNTHASE
(Homo
sapiens)		7 / 12ILE A 108
TRP A 109
LEU A 221
GLY A 222
PHE A 225
TYR A 258
ALA A 312
D16  A 414 (-3.7A)
D16  A 414 (-3.7A)
D16  A 414 (-4.0A)
D16  A 414 (-3.3A)
D16  A 414 (-3.6A)
UMP  A 314 ( 4.4A)
D16  A 414 (-3.6A)
0.93A50.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FQS_B_LYAB302_1
(THYMIDYLATE SYNTHASE)		3ifw UBIQUITIN
CARBOXYL-TERMINAL
HYDROLASE ISOZYME L1
(Homo
sapiens)		5 / 12GLU A 109
LEU A 106
GLY A 107
VAL A  99
ALA A 100
None
1.24A20.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FQS_B_LYAB302_1
(THYMIDYLATE SYNTHASE)		4l1m E3 UBIQUITIN-PROTEIN
LIGASE HERC2
(Homo
sapiens)		5 / 12GLU A 424
ILE A 426
ASP A 759
GLY A 757
VAL A 730
None
1.23A20.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FQS_B_LYAB302_1
(THYMIDYLATE SYNTHASE)		4um8 INTEGRIN ALPHA-V
(Homo
sapiens)		5 / 12ILE A 433
GLY A 405
PHE A 404
VAL A  23
ALA A  22
None
1.22A17.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FQS_B_LYAB302_1
(THYMIDYLATE SYNTHASE)		5lst ATP-DEPENDENT DNA
HELICASE Q4
(Homo
sapiens)		5 / 12HIS A 930
ILE A1051
LEU A 923
VAL A 842
ALA A 841
None
1.02A16.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FQS_B_LYAB302_1
(THYMIDYLATE SYNTHASE)		5njj PROTEIN NUMB HOMOLOG
(Homo
sapiens)		5 / 12GLU A 112
LEU A  95
GLY A  94
VAL A 158
ALA A 157
None
1.24A16.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FQS_B_LYAB302_1
(THYMIDYLATE SYNTHASE)		6eti ATP-BINDING CASSETTE
SUB-FAMILY G MEMBER
2
(Homo
sapiens)		5 / 12ILE A 239
ASP A 254
LEU A  75
GLY A  74
ALA A 270
None
1.24A13.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KN2_A_LYAA304_1
(FOLATE RECEPTOR BETA)		2c11 MEMBRANE COPPER
AMINE OXIDASE
(Homo
sapiens)		5 / 12ASP A 476
THR A 477
SER A 644
GLY A 390
TYR A 490
None
1.40A13.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4KN2_A_LYAA304_1
(FOLATE RECEPTOR BETA)		4kmz FOLATE RECEPTOR BETA
(Homo
sapiens)		5 / 12ASP A  97
ARG A 122
HIS A 151
GLY A 153
TRP A 187
FOL  A 301 (-2.8A)
FOL  A 301 ( 4.4A)
FOL  A 301 (-3.9A)
FOL  A 301 (-4.0A)
FOL  A 301 (-3.5A)
1.09A100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4KN2_A_LYAA304_1
(FOLATE RECEPTOR BETA)		4kmz FOLATE RECEPTOR BETA
(Homo
sapiens)		12 / 12ASP A  97
THR A  98
TYR A 101
SER A 117
TRP A 118
ARG A 119
HIS A 151
GLY A 153
TRP A 156
TRP A 187
SER A 190
TYR A 191
FOL  A 301 (-2.8A)
FOL  A 301 ( 4.6A)
FOL  A 301 (-3.8A)
FOL  A 301 (-3.5A)
FOL  A 301 (-4.0A)
FOL  A 301 (-3.0A)
FOL  A 301 (-3.9A)
FOL  A 301 (-4.0A)
FOL  A 301 (-3.7A)
FOL  A 301 (-3.5A)
FOL  A 301 (-2.6A)
FOL  A 301 (-4.1A)
0.32A100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4KN2_A_LYAA304_1
(FOLATE RECEPTOR BETA)		4lrh FOLATE RECEPTOR
ALPHA
(Homo
sapiens)		5 / 12ASP A  81
ARG A 106
HIS A 135
GLY A 137
TRP A 171
FOL  A 301 (-2.7A)
FOL  A 301 (-3.8A)
FOL  A 301 (-4.1A)
FOL  A 301 (-4.3A)
FOL  A 301 (-3.7A)
0.94A77.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4KN2_A_LYAA304_1
(FOLATE RECEPTOR BETA)		4lrh FOLATE RECEPTOR
ALPHA
(Homo
sapiens)		12 / 12ASP A  81
THR A  82
TYR A  85
SER A 101
TRP A 102
ARG A 103
HIS A 135
GLY A 137
TRP A 140
TRP A 171
SER A 174
TYR A 175
FOL  A 301 (-2.7A)
None
FOL  A 301 (-4.1A)
FOL  A 301 (-3.5A)
FOL  A 301 (-4.2A)
FOL  A 301 (-3.2A)
FOL  A 301 (-4.1A)
FOL  A 301 (-4.3A)
FOL  A 301 (-3.6A)
FOL  A 301 (-3.7A)
FOL  A 301 (-2.8A)
FOL  A 301 (-4.1A)
0.44A77.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KN2_A_LYAA304_2
(FOLATE RECEPTOR BETA)		3p30 1281 FAB HEAVY CHAIN
1281 FAB LIGHT CHAIN
HIV-1 GP41
(Homo
sapiens;
Human
immunodeficiency
virus
1)		4 / 4TYR L  49
GLN A 650
ARG H  94
TRP H 103
None
1.13A18.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4KN2_A_LYAA304_2
(FOLATE RECEPTOR BETA)		4kmz FOLATE RECEPTOR BETA
(Homo
sapiens)		4 / 4TYR A  76
GLN A 116
ARG A 152
TRP A 154
FOL  A 301 (-3.8A)
FOL  A 301 ( 4.8A)
FOL  A 301 (-4.0A)
None
0.16A100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KN2_B_LYAB304_1
(FOLATE RECEPTOR BETA)		1soj CGMP-INHIBITED
3',5'-CYCLIC
PHOSPHODIESTERASE B
(Homo
sapiens)		5 / 12ASP A 937
THR A 893
HIS A 825
ARG A 732
GLY A 730
 MG  A2123 (-2.5A)
None
None
None
None
1.27A18.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4KN2_B_LYAB304_1
(FOLATE RECEPTOR BETA)		4kmz FOLATE RECEPTOR BETA
(Homo
sapiens)		6 / 12ASP A  97
ARG A 122
HIS A 151
ARG A 152
GLY A 153
TRP A 187
FOL  A 301 (-2.8A)
FOL  A 301 ( 4.4A)
FOL  A 301 (-3.9A)
FOL  A 301 (-4.0A)
FOL  A 301 (-4.0A)
FOL  A 301 (-3.5A)
1.42A100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4KN2_B_LYAB304_1
(FOLATE RECEPTOR BETA)		4kmz FOLATE RECEPTOR BETA
(Homo
sapiens)		12 / 12ASP A  97
THR A  98
TYR A 101
TRP A 118
ARG A 119
HIS A 151
ARG A 152
GLY A 153
TRP A 156
TRP A 187
SER A 190
TYR A 191
FOL  A 301 (-2.8A)
FOL  A 301 ( 4.6A)
FOL  A 301 (-3.8A)
FOL  A 301 (-4.0A)
FOL  A 301 (-3.0A)
FOL  A 301 (-3.9A)
FOL  A 301 (-4.0A)
FOL  A 301 (-4.0A)
FOL  A 301 (-3.7A)
FOL  A 301 (-3.5A)
FOL  A 301 (-2.6A)
FOL  A 301 (-4.1A)
0.29A100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4KN2_B_LYAB304_1
(FOLATE RECEPTOR BETA)		4lrh FOLATE RECEPTOR
ALPHA
(Homo
sapiens)		5 / 12ASP A  81
ARG A 106
HIS A 135
GLY A 137
TRP A 171
FOL  A 301 (-2.7A)
FOL  A 301 (-3.8A)
FOL  A 301 (-4.1A)
FOL  A 301 (-4.3A)
FOL  A 301 (-3.7A)
0.94A77.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4KN2_B_LYAB304_1
(FOLATE RECEPTOR BETA)		4lrh FOLATE RECEPTOR
ALPHA
(Homo
sapiens)		11 / 12ASP A  81
THR A  82
TYR A  85
TRP A 102
ARG A 103
HIS A 135
GLY A 137
TRP A 140
TRP A 171
SER A 174
TYR A 175
FOL  A 301 (-2.7A)
None
FOL  A 301 (-4.1A)
FOL  A 301 (-4.2A)
FOL  A 301 (-3.2A)
FOL  A 301 (-4.1A)
FOL  A 301 (-4.3A)
FOL  A 301 (-3.6A)
FOL  A 301 (-3.7A)
FOL  A 301 (-2.8A)
FOL  A 301 (-4.1A)
0.42A77.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KN2_C_LYAC304_1
(FOLATE RECEPTOR BETA)		2c11 MEMBRANE COPPER
AMINE OXIDASE
(Homo
sapiens)		5 / 12ASP A 476
THR A 477
SER A 644
GLY A 390
TYR A 490
None
1.39A13.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4KN2_C_LYAC304_1
(FOLATE RECEPTOR BETA)		4kmz FOLATE RECEPTOR BETA
(Homo
sapiens)		5 / 12ASP A  97
ARG A 122
HIS A 151
GLY A 153
TRP A 187
FOL  A 301 (-2.8A)
FOL  A 301 ( 4.4A)
FOL  A 301 (-3.9A)
FOL  A 301 (-4.0A)
FOL  A 301 (-3.5A)
1.08A100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4KN2_C_LYAC304_1
(FOLATE RECEPTOR BETA)		4kmz FOLATE RECEPTOR BETA
(Homo
sapiens)		12 / 12ASP A  97
THR A  98
TYR A 101
SER A 117
TRP A 118
ARG A 119
HIS A 151
GLY A 153
TRP A 156
TRP A 187
SER A 190
TYR A 191
FOL  A 301 (-2.8A)
FOL  A 301 ( 4.6A)
FOL  A 301 (-3.8A)
FOL  A 301 (-3.5A)
FOL  A 301 (-4.0A)
FOL  A 301 (-3.0A)
FOL  A 301 (-3.9A)
FOL  A 301 (-4.0A)
FOL  A 301 (-3.7A)
FOL  A 301 (-3.5A)
FOL  A 301 (-2.6A)
FOL  A 301 (-4.1A)
0.28A100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4KN2_C_LYAC304_1
(FOLATE RECEPTOR BETA)		4lrh FOLATE RECEPTOR
ALPHA
(Homo
sapiens)		5 / 12ASP A  81
ARG A 106
HIS A 135
GLY A 137
TRP A 171
FOL  A 301 (-2.7A)
FOL  A 301 (-3.8A)
FOL  A 301 (-4.1A)
FOL  A 301 (-4.3A)
FOL  A 301 (-3.7A)
0.93A77.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4KN2_C_LYAC304_1
(FOLATE RECEPTOR BETA)		4lrh FOLATE RECEPTOR
ALPHA
(Homo
sapiens)		12 / 12ASP A  81
THR A  82
TYR A  85
SER A 101
TRP A 102
ARG A 103
HIS A 135
GLY A 137
TRP A 140
TRP A 171
SER A 174
TYR A 175
FOL  A 301 (-2.7A)
None
FOL  A 301 (-4.1A)
FOL  A 301 (-3.5A)
FOL  A 301 (-4.2A)
FOL  A 301 (-3.2A)
FOL  A 301 (-4.1A)
FOL  A 301 (-4.3A)
FOL  A 301 (-3.6A)
FOL  A 301 (-3.7A)
FOL  A 301 (-2.8A)
FOL  A 301 (-4.1A)
0.44A77.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KN2_C_LYAC304_2
(FOLATE RECEPTOR BETA)		1kwm PROCARBOXYPEPTIDASE
B
(Homo
sapiens)		3 / 3TYR A 208
GLN A 261
TRP A 151
None
0.93A19.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KN2_C_LYAC304_2
(FOLATE RECEPTOR BETA)		1x5i NEOGENIN
(Homo
sapiens)		3 / 3TYR A  78
GLN A  53
TRP A  47
None
1.15A16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KN2_C_LYAC304_2
(FOLATE RECEPTOR BETA)		1zli CARBOXYPEPTIDASE B
(Homo
sapiens)		3 / 3TYR A 208
GLN A 261
TRP A 151
None
0.95A20.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KN2_C_LYAC304_2
(FOLATE RECEPTOR BETA)		2r7e COAGULATION FACTOR
VIII
(Homo
sapiens)		3 / 3TYR B2256
GLN B2284
TRP B2313
None
0.81A14.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KN2_C_LYAC304_2
(FOLATE RECEPTOR BETA)		2xy9 ANGIOTENSIN-CONVERTI
NG ENZYME
(Homo
sapiens)		3 / 3TYR A 520
GLN A 493
TRP A 467
3ES  A1635 (-4.7A)
None
None
1.05A15.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KN2_C_LYAC304_2
(FOLATE RECEPTOR BETA)		2xyd ANGIOTENSIN-CONVERTI
NG ENZYME
(Homo
sapiens)		3 / 3TYR A 498
GLN A 471
TRP A 445
3ES  A1611 (-4.7A)
None
None
1.03A15.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KN2_C_LYAC304_2
(FOLATE RECEPTOR BETA)		3mop INTERLEUKIN-1
RECEPTOR-ASSOCIATED
KINASE-LIKE 2
(Homo
sapiens)		3 / 3TYR K   6
GLN K  73
TRP K  63
None
1.00A22.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KN2_C_LYAC304_2
(FOLATE RECEPTOR BETA)		3p30 1281 FAB HEAVY CHAIN
1281 FAB LIGHT CHAIN
HIV-1 GP41
(Homo
sapiens;
Human
immunodeficiency
virus
1)		3 / 3TYR L  49
GLN A 650
TRP H 103
None
1.09A18.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KN2_C_LYAC304_2
(FOLATE RECEPTOR BETA)		3qk3 BETA-CRYSTALLIN B3
(Homo
sapiens)		3 / 3TYR A 178
GLN A  78
TRP A 181
None
0.96A21.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KN2_C_LYAC304_2
(FOLATE RECEPTOR BETA)		4a0k CULLIN-4A
(Homo
sapiens)		3 / 3TYR A 536
GLN A 673
TRP A 569
None
1.05A15.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KN2_C_LYAC304_2
(FOLATE RECEPTOR BETA)		4a0l CULLIN-4B
(Homo
sapiens)		3 / 3TYR E 690
GLN E 827
TRP E 723
None
1.13A13.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KN2_C_LYAC304_2
(FOLATE RECEPTOR BETA)		4ig8 2'-5'-OLIGOADENYLATE
SYNTHASE 1
(Homo
sapiens)		3 / 3TYR A 216
GLN A 318
TRP A 326
None
1.11A16.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4KN2_C_LYAC304_2
(FOLATE RECEPTOR BETA)		4kmz FOLATE RECEPTOR BETA
(Homo
sapiens)		3 / 3TYR A  76
GLN A 116
TRP A 154
FOL  A 301 (-3.8A)
FOL  A 301 ( 4.8A)
None
0.20A100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4KN2_C_LYAC304_2
(FOLATE RECEPTOR BETA)		4lrh FOLATE RECEPTOR
ALPHA
(Homo
sapiens)		3 / 3TYR A  60
GLN A 100
TRP A 138
FOL  A 301 (-3.9A)
FOL  A 301 (-4.3A)
None
0.45A77.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KN2_C_LYAC304_2
(FOLATE RECEPTOR BETA)		5d1z IRON-REGULATED
SURFACE DETERMINANT
PROTEIN B
Y10 HEAVY CHAIN
(Homo
sapiens;
Staphylococcus
aureus)		3 / 3TYR B 108
GLN I 127
TRP B  34
None
0.93A19.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KN2_C_LYAC304_2
(FOLATE RECEPTOR BETA)		5tqw INHIBITOR OF NUCLEAR
FACTOR KAPPA-B
KINASE SUBUNIT ALPHA
(Homo
sapiens)		3 / 3TYR A 204
GLN A 285
TRP A 205
None
1.04A13.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KN2_C_LYAC304_2
(FOLATE RECEPTOR BETA)		5vfr PROTEASOME SUBUNIT
ALPHA TYPE-4
(Homo
sapiens)		3 / 3TYR I 156
GLN I 146
TRP I 159
None
1.17Aundetectable